An active practicing New York Cardiologist with over two decades of experience, Dr. Hershman is also recognized as a successful entrepreneur, and has been involved in life science investing, evaluation and consulting. He currently serves on the boards of several companies including TheraVitae, Inc., InMotion, Inc. and Optivasive Ltd., as well as an advisor to Life Sciences Opportunities Fund, LP, a $100 million,
late-stage life science venture capital company.
CEO
Amir Zalcenstein, PhD, MBA
Dr. Zalcenstein comes to SoluBest after working with a business development and public relations consulting firm, and later with Ernst & Young's GIA division as a senior consultant. Amir holds a doctoral degree in cancer genetics from the Weizmann Institute of Science, and did a post-doctorate in Nano-technology. He joined SoluBest in 2007.
Chief Technology Officer Maryana Averbuch, PhD.
Dr. Averbuch brings over 25 years of scientific expertise in polymer and physical chemistry, including most recently experience in the field of innovative pharmaceuticals at D-Pharm, Rehovot. Maryana holds a Ph.D. from Moscow University, Russia.
R&D Manager Galia Temstin-Krayz, PhD.
Galia directs SoluBest Formulation R&D, analytical method development, process optimization and scale-up. She earned her PhD in Organic and Material Chemistry from Ben Gurion University in Beer Sheva, Israel.
She has both academic and industrial experience in organic synthesis and process development of APIs.
